Endothelial dysfunction in atherosclerosis

Journal of Vascular Research

Volumn 33, Issue 3, 1996, Pages 181-194

  Busse, Rudi ^a   Fleming, Ingrid ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Adhesion molecules; Low density lipoprotein; Nitric oxide; Nuclear factor kappa B; Superoxide anion

Indexed keywords

ARGININE; BRADYKININ; CHOLESTEROL; CYCLIC GMP; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; SUPEROXIDE; TRANSCRIPTION FACTOR;

ATHEROSCLEROSIS; ENDOTHELIUM INJURY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0029885126     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159147     Document Type: Article

References (185)

1. Munro JM, Cotran RS: The pathogenesis of atherosclerosis: Atherogenesis and inflammation, Lah Invest 1988;58:249-261.
2. Ross R, Clomset J, Harker L: Response to injury and atherogenesis, Am J Pathol 1977:86; 675-684.
3. 2+ sensitivity for contraction of smooth muscle, Can J Physiol Pharmacol 1994:72:1434-1439.
4. Gintbrone MA Jr.: Endothelial dysfunction and the pathogenesis of atherosclerosis: in Gotto A, Smith LC, Allen B (eds): Atherosclerosis V, Proc Symp on Athcrsclerosis, New York, Springer 1980, pp 415-425.
5. Cornhill JF, Roach MR: A quantativc study of the localization of atherosclerotic lesions in the rabbit aorta, Atherosclerosis 1976:23:489-499.
6. Yoshida Y, Sue W, Okano M, Ovama T, Ya-rnane T, Mitsumata M: The effects of augmented hemodynamic forces on the progression of atherosclerotic plaques, Ann NY Acad Sci 1990:598:256-273.
7. Zarins CK, Giddens DP, Bharadvaj BK, Sot-tiuari VS, Mabon RF, Glagov S: Carotid bifurcation atherosclerosis, Quantitative correlation of plaque localisation with flow velocity profiles and wall shear stress, C'ric Res 1983:53:502-514.
8. Ku DN, Giddens DP, Zarins CK, Glagov S: Pulsatile flow and atherosclerosis in the human carotid bifurcation, Positive correlation between plaque location and low oscillating shear stress, Arteriosclerosis 1985:5:293-301.
9. Nerem RM: Atherosclerosis and the role of wall shear stress: in Bevan JA, Kaley G, Ruba-nyi GM (eds): Flow-dependent regulation of vascular function, New York, Oxford University Press, 1995. pp 214-315.
10. Busse R, Fleming I: Regulation and functional consequences of endothelial nitric oxide formation, Ann Med 1995;27:331-340
11. Busse R, Miilsch A, Fleming I, Meeker M: Mechanisms of nitric oxide release from the vascular endothelium, Circulation 1993:87: (suppl, V):V18-V25.
12. Lamontagne D, Pohl U, Busse R: Mechanical deformation of the vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed, Circ Res 1992:70:123-130
13. Bevan JA, Kaley G, Rubanyi GM: Flow-dependent regulation of vascular function, New York, Oxford University Press, 1995.
14. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase, Nature 1995:377: 239-242.
15. Avajiki K, Kindermann M, flecker M, Fleming I, Busse R: Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells, Circ Res 1996:78:743-751.
16. Kuchan MJ, Frangos JA: Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells, Am J Physiol 1994: 266:C628-C636.
17. Fleming I, Bauersaehs J, Fisslthaler B, Busse R: Calcium-independent activation of the endothelial NO synthase via shear stress and tyrosine phosphatase inhibition (abstract), FASF, B J 1996;10:A319.
18. Martin W, While DG, Henderson AH: Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells, Br J Pharmacol 1988:93:229-239.
19. Kobayashi S, Kanaidc H, Nakamura M: Cytosolic free calcium transients in cultured vascular smooth muscle cells: Microfluorometric measurements, Science 1985:229:533-556.
20. 2+ in cultured vascular smooth muscle cells, Am J Physiol 1986:251 :C681-C686.
21. Kai H, Kanaidc H, Matsumolo T, Nakamura M: 8-Bromoguanosine 3 :5'-cyclic monophosphate decreases intracellular free calcium concentrations in cultured vascular smooth muscle cells from the rat aorta, FEBS Lett 1987:221: 284-288.
22. Walter U: Physiological role of cGMP and cAMP-depcndcnt protein kinase in the cardiovascular system, Rev Physiol Biochem Pharmacol 1989:113:41-88.
23. Shah AM, Spurgeon H, Sollott SJ, Talo A, Lakatta EG: 8-Bromo cyclic GMP reduces the myofilament response to calcium in intact cardiac myocytes, Circ Res 1994:74:970-978.
24. 2+ current, J Biol Chem 1993:268:26286-26295.
25. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle, Nature 1994:368:850-853.
26. Archer SL, Huang JMC, Hampl V, Nelson DP, Shultz PJ, Weir EK: Nitric oxide and cGMP cause vasorelaxation by activation of a charvb-dotoxin-scnsilive K channel by cGMP-depen-dent protein kinase, Proc Natl Acad Sci USA 1994:91:7583-7587.
27. Pawson T: Regulation of the Ras signalling pathway by protein-tyrosine kinases, Biochem Soc Trans 1994:22:455-460
28. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R: Nitric oxide modulates the expression of monocyte chemoattractant protein I in cultured human endothelial cells, C'irc Res 1995: 76:980-986.
29. De Catcrina R, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr., Shin WS, Liao JK: Nitric oxide decreases cytokine-induced endothelial activation, J Clin Invest 1995:96:60-68.
30. Nabel EG, Selwyn AP, Ganz P: Large coronary arteries in humans are responsive to changing blood How: An endothelium-dependent mechanism that fails in patients with atherosclerosis, J Am Coll Cardiol 1990:16:349-356.
31. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, van Hove CE, Cocnc MC, Herman AG: Effect of hypercholesterolemia on vascular reactivity in the rabbit, Circ Res 1983:53:63.
32. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries, N Engl , J Med 1986:315:1046-1051.
33. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG: Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates, Circ Res 1986:58:783-789.
34. Bosaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD: Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine-5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta, J Clin Invest 1987:79:170-182.
35. Chester AH, ONeil GS, Moncada S, Tadjkar-imi S, Yacoub MIL Low basal and stimulated release of nitric oxide in atherosclerotic epicar-dial coronary arteries, Lancet 1990:336:897-900
36. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SH, Coleman SM, Loscalzo J, Dzau VJ: Impaired vasodilation of forearm resistance vessels in hypcrcholcstcrolemic humans, J Clin Invest 1990:86:228-234.
37. Zeiher AM, Drexler H, Wollschlager H, Just H: Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis, Circulation 1991:84: 1984-1992.
38. Zeiher AH, Drexler H, Wollschlagcr H, Just H: Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis, Circulation 1991;83:391-401.
39. Heistad DD, Armstrong ML, Marcus ML, Pie-gors DJ, Mark AL: Augmented responses to vasoconstrictor stimuli in hypercholesterol-emic and atherosclerotic monkeys, Circ Res 1984:54:711-719.
40. Yokoyama M, Akita H, Mizutani T, Fukuzaki H, Walanabe Y: Hyperreactivity of coronary arterial smooth muscles in response toergono-vinc from rabbits with hereditary hyperlipid-emia, Circ Res 1983:53:63-69.
41. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP: Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test, Circulation 1988:77:43-52.
42. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ, Ganz P, Selwyn AP:The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress, N Engl J Med 1991:325:1551-1556.
43. Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, Takeshita A: Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions, J Clin Invest 1993:91:29-37.
44. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A: Evidence of impaired endothelium-dependent coronary' vasodilation in patients with angina pectoris and normal angiograms, N Engl J Med 1993:328:1659-1664.
45. Reddy KG, Nair RN, Sheehan 1IM, Hodgson JM: Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis, J Am Coll Cardiol 1994;23:833-843.
46. Cayalte AJ, Palacino JJ, Horten K, Cohen RA: Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholcsterolemic rabbits, Arteriosclcr Thromb 1994:14:753-759.
47. Liao JK, Shin WS, Lee WY, Clark SL: Oxidised low-dcnsity lipoprotein decreases the expression of endothelial nitric oxide synthase, J Biol Chem 1995;270:319-324.
48. Yoshizumi M, Perrelta MA, Burnett JC Jr., Lee M-E: Tumor necrosis factor downregulatcs an endothelial nitric oxide synthase mRNA by shortening its half-life, Circ Res 1993.73:205-209.
49. Minor RL Jr., Myer PR, Guerra R Jr., BatesJN, Harrison DG: Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta, J Clin Invest 1990:86:2109-2116.
50. Zembowicz A, Tang J, Wu KK: Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholinc, J Biol Chem 1995:270:17006-17010.
51. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG: l, vsophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation, Arterioscler Thromb 1994:14:1007-1013.
52. Yanagisawa M, Kurihara H, Klimura S, To-mobc Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 1988:332:411-415.
53. Luscher TF, Boulanger CM, Dohi Y, Yang Z: Endothelium-derived contracting factors, Hypertension 1992; 19:117-130
54. Boulanger CM, Luscher TF: Release of endo-thelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide, J Clin Invest, 1990:85:587-590
55. Saijonmaa O, Ristimaki A, Fyhrquist F: Atrial natriuretic peptide, nitroglycerine, and nitro-prusside reduce basal and stimulated endothe-lin production from cultured endothelial cells, Biochem Biophvs Res Commun 1990:173: 514-520
56. Lerrnan A, Burnett JC Jr.: Intact and altered endothelium in regulation of vasomotion, Circulation 1992:86(suppl 3):111-12-111-19.
57. Winkles JA, Alberts GE, Brogi E, Libby P: Endothelin-1 and endothclin receptor ntRNA expression in normal and atherosclerotic human arteries, Biochcm Biophvs Res Commun 1993:191:1081-1088.
58. Miller RC, Pelton JT, Huggins JP: Endothelins - from receptors to medicine, Trends Pharmacol Sci 1993:14:54-60
59. Luscher TF, Seo B, Bühler FR: Potential role of endothelin in hypertension, Hypertension 1993;21:753-756.
60. Girerd XL, Hirsch AT, Cooke JP, Dzau VJ, Creager MA: L,-arginine augments endothe-lium-depcndent vasodilation in cholesterol-fed rabbits, Circ Res 1990:315:1046-1051.
61. Cooke JP, Andon NA, Girerd XL, Hirsch AT, Creager MA: Arginine restores cholinergic relaxation of hypercholcsterolemic rabbit thoracic aorta, Circulation 1991;83:1057-1062.
62. Creager MA, Gircrd XL, Gallagher SJ, Coleman S, Dzau VJ, Cooke JP: L,-arginine improves endothelium-dependent vasodilation in hypcrcholesterolemic humans, J Clin Invest 1992;90:1168-1172.
63. Drexler H, Fischell TA, Pinto FJ, Chenzbraun A, Botas J, Cooke JP, Alderman EL: Effect of L,-arginine on coronary endothelial function in cardiac transplant recipients, Circulation 1994: 89:1615-1623.
64. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billinghant ME: Antiatherogenic effects of L-argininc in the hypercholcsterolemic rabbit, J Clin Invest 1992:90:1168-1172.
65. Wang B-Y, Singer AH, Tsao PS, Drexler H, Kosek J, Cooke JP: Dietary arginine prevents atherogenesis in the coronary' artery of the hv-percholcsterolcmic rabbit, J Am Coll Cardiol 1994;23:452-458.
66. Tsao PS, McEvov LM, Drexler H, Butcher EC, Cooke JP: Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine, Circulation 1994:89:2176-2182.
67. Imaizumi T, Hirooka Y, Masaki H: Effects of L,-arginine on forearm vessels and responses to acetylcholine, Hypertension 1992:20:511-517.
68. Panza JA, Casino PR, Badar DM, Quyyumi AA: Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension, Circulation 1993:87:1475-1481.
69. Casino PR, Kilcoyne CM, Quyvuni AA, Hocg JM, Panza JA: Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypcrcholcsterol-ernic patients, J Am Coll Cardiol 1994:23:844-850
70. Calver A, Collier J, Vallanee P: Dilator actions of arginine in human peripheral vasculature, ClinSci 1991:81:695-700
71. Hutcheson IR, Smith JA, Griffith TM: Abolition of flow-dependent F, DRF release before that evoked by agonists in hvpercholestcro-lacntic rabbits, BrJ Pharmacol 1994:113:190-194.
72. Pritchard KA Jr., Groszck L, Smalley DM, Scs-sa WC, Wu M, Villalon P, Wolin MS, Stcmer-man MB: Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of supcroxide anion, Circ Res 1995: 77:510-518.
73. Clancy RM, Leszczynska-Piziak J, Abramson SB: Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil supcroxide anion production via a direct action on the NADPH oxidase, J Clin Invest 1992:90:1116-1121.
74. Wiedermann CJ, Sitte B, Zilian U, Rcinisch N, Beimpold H, Finkensledt G, Braunsteincr H: Inhibition of superoxide anion release from circulating neutrophils by L,-arginine in man, Clin Invest 1993;71:985-989.
75. Arnal J-F, Münzel T, Vcnema RC, James NL, Bai C, Mitch WE, Harrison DG: Interactions between E-arginine and L,-glutamine change endothelial NO production, J Clin Invest 1995: 95:2565-2572.
76. Baydoun AR, Emery PW, Pearson JD, Mann GE: Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells, Biochcm Bio-phys Res Commun 1990:173:940-948.
77. Hecker M, Sessa WC, Harris HJ, Anggard EE, Vane JR: The metabolism of L,-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle E-citrulline to L,-arginine, Proc Natl Acad Sci USA 1990:87:8612-8616.
78. Pollock JS, Forstcrmann U, Mitchell JA, WarnerTD, Schmidt HHHW, Nakanc M, Murad F: Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells, Proc Natl Acad Sci USA 1991;88:10480-10484.
79. G-dimclhylarginine dime-thylaminohydrolase in human tissues using a monoclonal antibody, J Biochem 1995:117: 237-238.
80. Vallance P, Leone A, Calver A, Collier J, Mon-cada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure, Lancet 1992;339:572-575.
81. G dimcthvlargin-ine by human endothelial cells, Endothelium 1993;1:137-140
82. MacAllistcr RJ, Whitley GSJ, Vallancc P: Effects of guanidino and uremic compounds on nitric oxide pathways, Kidney hit 1994:45: 737-742.
83. Yu X, Li Y, Xiong Y: Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits, Life Sci 1994;54:753-758.
84. Kurose I, Wolf R, Grisham MB, Granger DN: Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillarv venules, Am J Physiol 1995:268:H2224-H2231.
85. Mügge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG: Chronic treatment with polycthylcne-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits, Circ Res 1991:69:1293-1300
86. Keaney JFJ, Gaziano JM, Xu Z, Frei B, Cur-ran-Celentano J, Schwacry GT, Loscalzo J, Vita JA: Dietary antioxidants preserve endothelium-dependent vessel relaxation in choles-terol-fcd rabbits, Proc Natl Acad Sci USA 1993:90:11880-11884.
87. Keaney JFJ, Gaziano JM, Xu Z, Frei B, Cur-ran-Celentano J, Schwacry GT, Loscalzo J, Vita JA: Low dose of a-locopherol worsens endothelial vasodilator function in cholesterol fed rabbits, J Clin Invest 1994:93:844-851.
88. Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial superox-idc anion production, J Clin Invest 1993:91: 2546-2551.
89. Miiggc A, Brandes RP, Boger RH, Dwcngcr A, Bodc-Bdger S, Kienke S, Frolich JC, Lichtlcn PR: Vascular release of superoxidc radicals is enhanced in hypercholcsterolemic rabbits, J Cardiovasc Pharmacol 1994:24:994-998.
90. Kritchevsky SB, Shimakawa T, Tell GS, Dennis B, Carpenter M, Eckfeldt JH, Peacher-Ryan H, Fleiss G: Dietary antioxidants and carotid artery’ wall thickness, Circulation 1995:92: 2142-2150
91. Harrison DG, Ohara Y: Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion, Am J Cardiol 1995;75:75B-81B
92. Mohazzab-H KM, Kaminski PM, Wolin MS: NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium, Am J Physiol 1994:266: H2568-H2572.
93. Holland JA, Pritchard KA Jr, Rogers NJ, Stc-merman MB, Perturbation of cultured human endothelial cells by atherogenic levels of low density lipoprotein, Am J Pathol 1988:132: 474-478.
94. Pritchard KA Jr., Wong P, Stemerman MB: Atherogenic concentrations of low density lipoprotein enhance endothelial cell generation of cpoxyeicosatrienoic acid products, Am J Pathol 1990; 136:1381-1391.
95. Ludwig PW, Hunninghake DB, Hoidal JR: Increased leukocyte oxidative metabolism in hvpcrlipoproteinaemia, Lancet 1982:2:348-350
96. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpev MM, White CR: Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohis-tochemistry, Biol Chem Hoppe-Seyle 1994:375:81-88.
97. Rengasamy A, Johns RA: Inhibition of nitric oxide synthase by a superoxide generating system, J Pharmacol Exp Ther 1993:267: 1024-1027.
98. Radi R, Beckman JS, Bush KM, Freeman BA: Pcroxvnitrite oxidation of sulphydryls, The cytotoxic potential of superoxidc and nitric oxide, J Biol Chem 1991:266:4244-4250
99. Wu M, Pritchard KA Jr, Kaminski PM, Favn-gersh RP, Hintze TH, Wolin MS: Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to pcroxyni-trite, AmJ Physiol 1994:266:H2108-H2113.
100. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, Beckman JS: Peroxyni-trile-mcdiated tyrosine nitration catalysed by superoxidc dismutase, Arch Biochem Bio-phys 1992;298:431-437.
101. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol, Modification of low-densitv lipoprotein that increase its atherogenicity, N Engl J Med 1989:320:915-926.
102. Witztum JL: The oxidation hypothesis of atherosclerosis, Lancet 1994:344:793-795.
103. Thorin E, Hamilton CA, Dominiczak MH, Reid J L: Chronic exposure of cultured bovine endothelial cells to oxidised LDL abolishes prostacyclin release, Arterioscler Thromb 1994:14:453-459.
104. Inoue N, Hirata K, Yamada M, Flamamori Y, Matsuda Y, Akita H, Yokoyama M: Lyso-phosphalidyleholinc inhibits bradykinin-in-duccd phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells, Circ Res 1992:71:1410-1421.
105. Liao JK: Inhibition of G, proteins by low density lipoprotein attenuates bradykinin-stimu-lated release of endothelial-derived nitric oxide, J Biol Chem 1994;269:12987-12992.
106. Liao JK, Clark SL: Regulation of G-protein Uj; subunit expression by oxidised low-densi-ty lipoprotein, J Clin Invest 1995:95:1457-1463.
107. Boulanger CM, Tanner FC, Bea M-L, Hahn AWW, Werner A, Luscher TF: Oxidised low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium, Circ Res 1992:70: 1191-1197.
108. deGraaf J: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotom subtraction in healthy subjects, Arterioscler Thromb 1991:11:298-306.
109. Krauss RM: Dense low density lipoproteins and coronary artery disease, Am J Cardiol 1995;75:53B-57B
110. Sleinbrecher UP, Parthasarathv S, Lcakc DS, Witztum JL, Steinberg D: Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation adn degradation of low-density lipoprotein phospholipids, Proc Natl Acad Sci USA 1984:81:3883-3887.
111. Heinecke JW, Rosen H, Chait A: Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture, J Clin Invest 1987:74:1890- 1894.
112. Cathcart MK, Morel DW, Chisolm GM III: Monocytes and neutrophils oxidize low-density lipoproteins making it cytotoxic, J Leu-koc Biol 1985;38:341-350
113. Yates MT, Lambert LE, Whitten JP, McDonald I. Mano M, Ku G, Mao SJT: A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages, FEBS Lett 1992:309:135-138.
114. Wang J-M, Chow S-N, Lin J-K: Oxidation of LDL by nitric oxide and its modification by supcroxides in macrophage and cell-free systems, FEBS Lett 1994:342:171-175.
115. Chang GJ, Woo P, Honda HM, lgnarro LJ, Young L, Berliner JA, Demcr LL: Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of supcroxidc: Dependence on pH and oxygen, Artcrioscler Thromb 1994:14:1808-1814.
116. Hogg N, Darlcy-Usmar VM, Wilson MT, Moncada S: The oxidation of a-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide, FEBS Lett 1993;326:199-203.
117. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S: The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein, Free Radie Res Commun 1992:17:9-20
118. Busse R, Fleming I: The endothelial organ, Curr Opin Cardiol 1993:8:719-727.
119. Doniniczak AF, Bohr DF: Nitric oxide and its putative role in hypertension, Hypertension 1995:25:1202-1211.
120. Taddei S, Virdis A, Mattei P, Arzilli F, Salvel-ti A: Endothelium-dependent forearm vasodilation is reduced in normotensive subjects with a family history' of hypertension, J Car-diovasc Pharmacol 1992:20(suppl 12):S193-S195.
121. Angus JA, Lew MJ: Interpretation of the acetylcholine test of endothelial dysfunction in hypertension, J Hypertens 1992:10(suppl 7): S179-S186.
122. Antony I, Lerebours G, Nilenberg A: Loss of flow-dependent coronary artery dilatation in patients with hypertension, Circulation 1995: 91:1624-1628.
123. Panza JA, Garcia CE, Kilcoyne CM, Quyyu-mi AA, Cannon RO: Impaired endothelium-dependent vasodilation in patients with essential hypertension, Circulation 1995:91: 1732-1738.
124. Higashi Y, Oshima T, Ozono R, Watanabe M, Matsuura H, Kajiyama G: Effects of L-argininc infusion on renal hemodynamics in patients with mild essential hypertension, Hypertension 1995:25:898-902.
125. Lee I, Webb RC: Endothelium-dependent relaxation and L,-arginine metabolism in genetic hypertension, Hypertension 1992:19:435-441.
126. Arvola P, Porsti I, Vuorinen P, Pekki A, Vapaatalo H: Contractions induced by potassium-free solution and potassium relaxation in vascular smooth muscle of hypertensive and normotensive rats, Br J Pharmacol 1992: 106:157-165.
127. Lin L, Balazy M, Pagano PJ, Nasjletti A: Expression of prostaglandin IT-mediated mechanism of vascular contraction in hypertensive rats, Circ Res 1994:74:197-205.
128. Kelm M, Feclisch M, Krebber T, Deussen A, Motz W, Strauer BE: Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats, Hypertension 1995:25:186-193.
129. Nava E, Noll G, Luscher TF: Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension, Circulation 1995:91:2310-2313.
130. Okada M, Fukuroda T, Shimamolo K, Taka-hashi R, Ikemoto F, Yano M, Nishikibe M: Antihypertensive effects of BQ-123. a selective endothclin ETA receptor antagonist, in spontaneously hypertensive rats treated with DOCA-salt, Eur J Pharmacol 1994:259: 339-342.
131. Kato T, Iw'ama Y, Hashimoto H, Ito T, Sa-take T: Prostaglandin H; may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat, Hypertension 1990;15:475-482.
132. Auch-Schwelk W, Kalusic Z, Vanhoutte PM: Thromboxane Ai-receptor antagonists inhibit endothelium-dependent contractions, Hypertension 1990;15:699-703.
133. Fu-Xiang D, Skopcc J, Diederich A, Dicder-ich D: Prostaglandin H; and thromboxane A; are contractile factors in intrarenal arteries of spontaneously hypertensive rats, Hypertension 1992:19:795-798.
134. Bank N, Ayncdjian HS: Role of thromboxane in impaired renal vasodilation response to acetylcholine in hypercholcsterolemic rats, J Clin Invest 1992:89:1636-1642.
135. Fortes ZB, Costa SG, Nigro D, Scivolctto R, Aparccida de Oliveira M, Catelli de Carvalho MH: Effect of indomelhacin on the microvessel reactivity of two-kidney, one-clip hypertensive rats, Arch lnl Pharmacodyn Ther 1992;316:75-89.
136. Taddci S, Virdis A, Mallei P, Salvetti A: Vasodilation to acetylcholine in primary and secondary forms of human hypertension, Hypertension 1993;21:929-933.
137. Chobanian AV, Forney Prescott M, Hauden-schild CC: Recent advances in molecular pathology: The effects of hypertension on the arterial wall, Exp Mol Pathol 1984:41:153-169.
138. Calver A, Collier J, Vallanee P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes, J Clin Invest 1992:90:2548-2554.
139. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA: Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence, N Engl J Med 1989:320:1025-1030
140. Corbett JA, Sweetland MA, Lancaster JR Jr., McDaniel ML: A l-hour pulse with IL-lp induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: Evidence for a tyrosine kinase signalling mechanism, FASEB J 1993:7:369-374.
141. Corbett JA, Sweetland MA, Wang JL, Lancaster JR Jr, McDaniel ML: Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islet of Langerhans, Proc Natl Acad Sci USA 1993:90:1731-1735.
142. Eizirik DL, Cagliero E, Björklund A, Welsh N: Interleukin-1 β induces the expression of an isoform of nilric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages, FEBS Lett 1992;308:249-252.
143. Delaney CA, Green M, Lowe J, Green I: Endogenous nitric oxide induced by interleu-kin-lp in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the ‘comet' assay, FEBS Lett 1993:333:291-295.
144. Carey JO, Azcvedo JL Jr, Morris PG, Pories WJ, Dohm GL: Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle, Diabetes 1995:44:682-688.
145. Oyama Y, Kawasaki H, Hattori Y, Kanno M: Attenuation of endothelium-dependent relaxation in aorta from diabetic rats, Eur J Pharmacol 1986:131:75-78.
146. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide release by glomeruli from diabetic rats, Metabolism 1995:44:695-698.
147. Rosen P, Ballhausen T, Bloch W, Addicks K: Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant, Diabctologia 1995;38:1157-1168.
148. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Emster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women, Ann Intern Med 1992:117:1016-1037.
149. Havashi T, Fukuto JM, lgnarro U, Chaudhu-ri G: Basal release of nitric oxide from aortic rings is greater in female than in male rabbits: Implications for atherosclerosis, Proc Natl Acad Sci USA 1992:89:11259-11263.
150. Gillian DM, Quyyunn AA, Cannon RO: Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women, Circulation 1994;89:2545-2551.
151. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles 1G, Moncada S: Induction of calcium-dependent nitric oxide synthases by sex hormones, Proc Natl Acad Sci USA 1994:91: 5212-5216.
152. Marsden PA, Hcng HHQ, Scherer SW, Stewart RJ, Hall AV, Shi X-M, Tsui L-C, Schap-pert KT: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene, J Biol Chem 1993: 268:17478-17488.
153. Celermajer DS, Sorensen KE, Georgakopou-los D, Bull C, Thomas O, Robinson J, Dcan-field JE, Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults, Circulation 1993:88: 2149-2155.
154. Zciher AM, Schachinger V, Minners J: Longterm cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function, Circulation 1995:92:1094-1100
155. Sicss W: Molecular mechanisms of platelet activation, Physiol Rev 1989:69:58-178.
156. Busse R, Fleming I: Regulation of platelet function by flow-induced release of endothelial autacoids; in Bevan JA, Kaley G, Rubanyi GM (eds): Flow-dependent regulation of vascular function, New York, Oxford University Press, 1995. pp 214-315.
157. Green L, Seroppian E, Handin RJ: Platelet activation during exercise-induced myocardial ischemia, N Engl J Med 1980:302:193-198.
158. Kumpuris AG, Luchi RJ, Waddell CC, Miller RR: Production of circulating platelet aggregates by exercise in coronary patients, Circulation 1980;61:62-65.
159. Mehta J, Mehta P, Pepine CJ: Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease, 3. Role of tachycardia stress and propranolol, Circulation 1978:58:881-886.
160. Sicss W, Lorenz R, Roth P, Weber PC: Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion, Circulation 1982:66:44-48.
161. Reilly CF, Kindy MS, Brown KF, Rosenberg RD, Sonenshcin GE: Heparin prevents vascular smooth muscle cell progression through the Gi phase of the cell cycle, J Biol Chem 1989:264:6990-6996.
162. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosinc monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells, J Clin Invest 1989:83:1774-1777.
163. Kariya K, Kawahara Y, Araki S, Fukuzaki H, Takai Y: Antiproliferative action of cyclic GMP-clevating vasodilators in cultured rabbit aortic smooth muscle cells, Atherosclerosis 1989:80:143-147.
164. Busse R, Mulsch A: Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells FEBS Lett 1990:275:87-90
165. Scotl-Burden T, Schini VB, Elizondo E, Jun-quero DC, Vanhoutte PM: Platelet-derived growth factor supresses and fibroblast growth factor enhances cvtokine-induced production of nitric oxide by cultured smooth muscle cells, Effects on cell proliferation, Circ Res 1992:71:1088-1100
166. Nunokawa Y, Tanaka S: Interferon-y inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation, Biochem Bio-phys RcsCommun 1992:188:409-415.
167. Verbeuren TJ, Bonhomme E, Laubic M, Si-moncl S: Evidence for the induction of non-endothclia! NO synthase in aortas from cholesterol-fed rabbits, J Cardiovasc Pharmacol 1993:21:841-845.
168. AB and PDGFbb in vascular smooth muscle cells, Eur J Pharmacol 1992:216:379-383.
169. Schini VB, Catovsky S, Durante W, Scott-Burden T, Schafer AI, Vanhoutte PM: Thrombin inhibits induction of nitric oxide synthase in vascular smooth muscle cells, Am J Physiol 1993;264:H611-H616.
170. Durante W, Schini VB, Kroll MH, Catovsky S, Scott-Burden T, While JG, Vanhoutte PM, Schafer AI: Platelets inhibit the induction of nitric oxide synthesis by intcrleukin-lp in vascular smooth muscle cells, Blood 1994:83: 1831-1838.
171. Sanders M: Molecular and cellular concepts in atherosclerosis, Pharntac Thcr 1994:61: 109-153.
172. Davenpcck KL, Gauthier TW, Lefcr AM: Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation, Gastroenterology 1994;107:1050-1058.
173. Rosen P, Schwippert P, Kaufman B, Tschopc D: Expression of adhesion molecules on the surface of activated platelets is diminished by PGL-analogues and an NO (EDRF)-donor: A comparison betw een platelets of healthy subjects and diabetic subjects, Platelets 1994:11: 42-57.
174. Gauthier TW, Davenpcck KL, Lefer AM: Nitric oxide attenuates leukocyte and endothelial interaction via P-selectin in splanchnic ischemia-rcperfusion, Am J Physiol 1994; 267:G562-G568.
175. Gaboury JP, Anderson DC, Kubes P: Molecular mechanisms involved in superoxide-in-duccd leukocyte and endothelial cell interactions in vivo, Am J Physiol 1994;266:H637-H642.
176. Yla-Hcrttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum J L, Steinberg D: Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions, Proc Natl Acad Sci USA 1991:88: 5252-5256.
177. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS: Cytokine-activated human endothelial cells synthetizc and secrete a monocyte chemoattractant, MCP-l/JE, Am J Pathol 1990; 136:1229-1233.
178. Satriano JA, Hora K, Shan Z, Stanley ER, Mori T, Schlondorff D: Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-y, tumor necrosis factor-u, IgG aggregates, and cAMP in mouse mesangial cells, J Immunol 1993:150:1971-1978.
179. Cushing SD, Berliner JA, Valente AJ, Tcrrito MC, Navab M, Parhanti F, Gerrity R, Schwartz CJ, Fogelman AM: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells, Proc Nati Acad Sci USA 1990:87:5134-5138.
180. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ: Molecular cloning and characterization of the constitutive bovsne aortic endothelial cell nitric oxide synthase, J Clin Invest 1992;90:2092-2096.
181. Ranjan V, Xiao Z, Diamond SL: Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress, Am J Physiol 1995;269:H550-H555.
182. Shyy Y-J, Hsieh H-J, Usami S, Chien S: Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium, Proc Natl Acad Sci USA 1994:91:4678-4682.
183. Peng H-B, Libby P, Liao JK: Induction and stabilization of IxBa by nitric oxide mediates inhibition of NFxB, J Biol Chem 1995:270: 14214-14219.
184. 2O: and antioxidants have opposite effects on activation of NF-kB and AP-I in intact cells: AP-1 as secondary antioxidant-rcsponsivc factor, EMBOJ 1993:12:2005-2015.
185. Tabuchi A, Sano K, Oh E, Tsuchiya T, Tsuda M: Modulation of AP-I activity by nitric oxide (NO) in vitro: NO-mcdialcd modulation of AP-1. FEBS Lett 1994:351:123-127.